Enzyme Replacement Therapy Medicines
Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV®) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase®) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal®)
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£6,079,596
Published
15 Aug 2024
Closes
15 Aug 2024
Procurement details
Source
Find a Tender
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Enzyme Replacement Therapy Medicines
£6,079,596
The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (e-g: VPRIV®/ Elaprase®/ Replagal®) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.
Delivery: Scotland
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.